Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;33(6):1846-1856.
doi: 10.1007/s11695-023-06556-9. Epub 2023 Apr 6.

One Anastomosis Gastric Bypass (OAGB) with a 150-cm Biliopancreatic Limb (BPL) Versus a 200-cm BPL, a Systematic Review and Meta-analysis

Affiliations
Review

One Anastomosis Gastric Bypass (OAGB) with a 150-cm Biliopancreatic Limb (BPL) Versus a 200-cm BPL, a Systematic Review and Meta-analysis

Mohamed AbdAlla Salman et al. Obes Surg. 2023 Jun.

Abstract

This is a systematic review and meta-analysis that assessed the impact of performing OAGB with a 150-cm BPL versus a 200-cm BPL concerning weight loss, comorbidities remission, and adverse nutritional effects. The analysis included studies that compared patients who underwent OAGB with a 150-cm BPL and 200-cm BPL. Eight studies were eligible for this review after searching in the EMBASE, PubMed central database, and Google scholar. The pooled analysis revealed favoring the 200-cm BPL limb length for weight loss, with a highly significant difference in the TWL% (p=0.009). Both groups showed comparable comorbidities remission. Significantly higher ferritin and folate deficiency rates were found in the 200-cm BPL group. Considering a 200-cm BPL when performing OAGB delivers a better weight loss outcome than a 150-cm BPL, which is at the expense of a more severe nutritional deficiency. No significant differences were found regarding the comorbidities' remission.

Keywords: 150 cm; 200 cm; Biliopancreatic limb length; Obesity; One anastomosis gastric bypass.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest

Figures

Fig. 1
Fig. 1
The included studies flow chart
Fig. 2
Fig. 2
Foster plots for the EWL% and TWL% in the included studies
Fig. 3
Fig. 3
Foster plots for diabetes mellitus and hypertension complete resolution/improvement in the included studies
Fig. 4
Fig. 4
Foster plot for hypoalbuminemia, low protein levels, and low ferritin levels in the included studies
Fig. 5
Fig. 5
Foster plot for low vitamin B12, folate, and vitamin D levels and high postoperative reoperation rate in the included studies
Fig. 6
Fig. 6
Foster plot for 30-days postoperative reoperation rate in the included studies
Fig. 7
Fig. 7
Review authors’ judgments about each risk of bias item for each included study

Similar articles

Cited by

References

    1. Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (N Y). 2017;2(7):e17. doi: 10.1097/IJ9.0000000000000017. - DOI - PMC - PubMed
    1. Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res. 2016;118(11):1844–1855. doi: 10.1161/CIRCRESAHA.116.307591. - DOI - PMC - PubMed
    1. Noun R, Skaff J, Riachi E. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22:697–703. doi: 10.1007/s11695-012-0618-z. - DOI - PubMed
    1. Lee WJ, Ser KH, Lee YC. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–1834. doi: 10.1007/s11695-012-0726-9. - DOI - PubMed
    1. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279–2289. doi: 10.1007/s11695-017-2666-x. - DOI - PMC - PubMed
  NODES
twitter 2